Malaria Prevention Pills: Side Effects Compared

Why do you need a prescription for malaria pills?

Antimalarial medications require a prescription because the choice depends on which drug-resistant malaria strains circulate at your specific destination, how long you will travel, your existing medications and potential interactions, and your medical history 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria. This article describes what each option tends to feel like and how to prepare for a more informed appointment.

What are the side effects of doxycycline for malaria?

How it works: An antibiotic that also prevents malaria when taken daily.

Common side effects: - Nausea and stomach upset — the most frequent complaint. Taking it with food and a full glass of water, and not lying down for 30 minutes afterward, reduces this significantly. - Increased photosensitivity — skin burns more easily in sunlight. Daily sunscreen and sun-protective clothing are essential at tropical destinations. - Esophageal irritation if taken without adequate water. - Vaginal yeast infections in some women, as doxycycline disrupts normal flora.

Less common: Diarrhea; rarely a severe photosensitive skin reaction — stop and contact your prescriber if blistering or peeling develops.

Who should not take it: Children under 8, pregnant individuals, and anyone with a tetracycline allergy.

Schedule: Start 1–2 days before travel, take daily throughout, continue for 4 weeks after leaving the malaria-risk area 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.

What are the side effects of atovaquone-proguanil (Malarone)?

How it works: A combination that attacks the malaria parasite at a different life-cycle stage than doxycycline or mefloquine.

Common side effects: - Nausea, abdominal pain, and vomiting — generally mild to moderate. Taking with food substantially reduces stomach symptoms. - Headache.

Less common: Diarrhea, dizziness, mouth sores.

Advantages: - No photosensitivity. - Shorter post-travel course: only 7 days after leaving the malaria zone, compared with 4 weeks for doxycycline. - Generally considered well tolerated; often preferred for shorter trips.

Limitation: More expensive per day than doxycycline, a meaningful consideration on long trips 2Ref 2U.S. Food and Drug Administration (2013).FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of potentially permanent neurologic side effects.FDA black-box warning for mefloquine neuropsychiatric and neurologic adverse effects (anxiety, depression, hallucinations, dizziness, loss of balance, tinnitus) that may persist or become permanent after stopping the drug.

Who should not take it: People with severe kidney disease; safety in pregnancy not established.

Schedule: Start 1–2 days before travel, take daily throughout, continue for 7 days after 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.

What are the neuropsychiatric risks of mefloquine (Lariam)?

How it works: A weekly tablet that prevents malaria.

Side effects — the reason it is less commonly chosen: In 2013 the FDA added a black-box warning to mefloquine's label specifically for neuropsychiatric adverse reactions, including vivid or disturbing dreams, insomnia, anxiety, depression, hallucinations, and loss of balance. These effects can persist long after stopping the drug 2Ref 2U.S. Food and Drug Administration (2013).FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of potentially permanent neurologic side effects.FDA black-box warning for mefloquine neuropsychiatric and neurologic adverse effects (anxiety, depression, hallucinations, dizziness, loss of balance, tinnitus) that may persist or become permanent after stopping the drug. The FDA also noted that dizziness, vertigo, tinnitus, and loss of balance can in some cases become permanent 2Ref 2U.S. Food and Drug Administration (2013).FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of potentially permanent neurologic side effects.FDA black-box warning for mefloquine neuropsychiatric and neurologic adverse effects (anxiety, depression, hallucinations, dizziness, loss of balance, tinnitus) that may persist or become permanent after stopping the drug.

Who should not take it: Anyone with a history of depression, anxiety disorders, psychosis, or seizures — a formal contraindication 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.

Advantage: Once-weekly dosing improves adherence for some travelers.

Practical note: Clinicians often recommend starting mefloquine 2–3 weeks before departure so that intolerable side effects appear while you are still at home.

Schedule: Start 2–3 weeks before travel, weekly throughout, continue for 4 weeks after 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.

When is chloroquine still appropriate?

How it works: The original antimalarial, taken weekly.

Side effects: Generally milder — nausea, headache, transient blurred vision, and itching (more common in people with darker skin tones).

The critical limitation: Chloroquine-resistant *P. falciparum* is now present in all of sub-Saharan Africa, most of South and Southeast Asia, and parts of South America 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria. In these regions — which represent most malaria-endemic destinations — chloroquine will not work. It remains appropriate only for limited areas where resistance has not developed (parts of Central America, the Caribbean, and the Middle East) 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.

Who cannot take it: People with psoriasis, porphyria, or retinal disease.

Schedule: Start 1–2 weeks before travel, weekly throughout, continue for 4 weeks after.

How does a clinician choose the right antimalarial for you?

The decision involves more than side-effect preference 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria2Ref 2U.S. Food and Drug Administration (2013).FDA Drug Safety Communication: FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of potentially permanent neurologic side effects.FDA black-box warning for mefloquine neuropsychiatric and neurologic adverse effects (anxiety, depression, hallucinations, dizziness, loss of balance, tinnitus) that may persist or become permanent after stopping the drug:

• Destination resistance map — which drugs are effective in your specific region
• Trip length — Malarone's higher cost per day matters more on a six-month trip; doxycycline's photosensitivity matters more on a beach itinerary
• Medical history — prior psychiatric history, kidney function, age, pregnancy status, current medications, and potential interactions
• Adherence habits — a weekly pill may suit someone who tends to forget daily doses
• Prior experience — a bad prior experience with one medication is relevant history

Arrive at the appointment knowing your destination region, travel dates, any prior antimalarial experience, and your full medication list 1Ref 1Centers for Disease Control and Prevention (2024).Malaria — Yellow Book.Destination resistance patterns; drug-specific indications, contraindications, and dosing schedules for malaria chemoprophylaxis; chloroquine resistance in sub-Saharan Africa and SE Asia; clinical selection criteria.